Clinical Trial Update: Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated the safety and tolerability of XF-73 Nasal Gel for nasal decolonisation of Staphylococcus aureus in healthy subjects, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infection

Drugs mentioned

• XF-73 Nasal Gel (XF-73)

Snippet

Sponsor: Destiny Pharma Plc | Conditions: Staphylococcus Aureus Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-10-07